Skip to main content
Sadhana Nitrochem Ltd. logo

Sadhana Nitrochem Ltd. — Investor Relations & Filings

Ticker · SADHNANIQ ISIN · INE888C01040 BSE.NS Manufacturing
Filings indexed 837 across all filing types
Latest filing 2022-02-23 Proxy Solicitation & In…
Country IN India
Listing BSE.NS SADHNANIQ

About Sadhana Nitrochem Ltd.

https://www.sncl.com

Sadhana Nitrochem Ltd. specializes in the manufacture of chemical intermediates and performance chemicals. The company's core product portfolio includes nitrobenzene and its downstream derivatives such as metanilic acid, aniline 2,5 disulphonic acid, and sodium meta nitrobenzene sulphonate. These products serve as critical raw materials for the global dyes, pigments, pharmaceuticals, and agrochemicals sectors. The company operates advanced manufacturing facilities focused on high-purity chemical synthesis and process optimization. Its technical capabilities extend to specialized chemical reactions including nitration, hydrogenation, and sulfonation. By maintaining a vertically integrated production model, the company ensures consistent quality and supply chain reliability for its international client base across various industrial applications.

Recent filings

Filing Released Lang Actions
This is with reference to our earlier submission of Postal Ballot Notice issued dated February 03, 2022 for the purpose of seeking member's approval by way of a Special Resolution to ....
Proxy Solicitation & Information Statement Classification · 95% confidence The document is an addendum to a Postal Ballot Notice dated February 3, 2022, concerning the issuance of equity share warrants on a preferential basis. It details changes and additions to the original Postal Ballot Notice, including removal and substitution of proposed allottees and an additional explanatory point regarding re-computation of issue price. The document is addressed to the Bombay Stock Exchange and shareholders, and it references compliance with the Companies Act, 2013 and SEBI regulations. The content is focused on informing shareholders about modifications to a voting notice related to capital issuance, not the actual voting results or the full postal ballot report itself. This fits the category of Proxy Solicitation & Information Statement (PSI), as it is a material sent to shareholders to provide information and request votes for meetings, specifically an addendum to a postal ballot notice. The document is substantive and not a mere announcement of a report, so it is not RPA or RNS. Therefore, the classification is PSI with high confidence.
2022-02-23 English
Pursuant to the above Regulations, we are enclosing herewith the copies of newspaper publication of Un-audited Financial results of the company for the quarter and nine months ended December ....
Interim / Quarterly Report Classification · 95% confidence The document contains detailed unaudited financial results for the quarter and nine months ended December 31, 2021, including revenue, net profit, earnings per share, and other financial metrics. It references approval by the Board of Directors and review by the Audit Committee, and it is filed pursuant to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The document includes multiple tables with substantive financial data and analysis for a period shorter than a full fiscal year. It is not merely an announcement or a certification but contains actual financial results. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2022-02-16 English
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015 read with Circular (Ref No. CIR/CFD/FAC/62/2016 dated July 05, 2016 we hereby ....
Interim / Quarterly Report Classification · 95% confidence The document is a formal communication from Sadhana Nitro Chem Limited to the Bombay Stock Exchange dated February 14, 2022. It reports the outcome of a Board meeting held on the same day. The key content includes approval of unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2021, along with a limited review report. The document contains detailed financial data for the specified period, including income, expenses, profit before tax, tax expenses, and earnings per share. It also includes notes explaining compliance with Indian Accounting Standards and SEBI regulations. The presence of unaudited financial results for a quarter and nine months period, along with a limited review report, indicates this is a quarterly/interim financial report. The document is substantive and contains actual financial data and analysis, not merely an announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2022-02-14 English
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015 read with Circular (Ref No. CIR/CFD/FAC/62/2016 dated July 05, 2016 we hereby ....
Interim / Quarterly Report Classification · 95% confidence The document is a formal communication from Sadhana Nitro Chem Limited to the Bombay Stock Exchange dated February 14, 2022. It reports the outcome of a Board meeting held on the same day. The key content includes approval of unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2021, along with a limited review report. The document contains detailed financial data for the specified period, including income, expenses, profit before tax, tax expenses, and earnings per share. It also includes notes explaining the preparation and review of these financial results in compliance with SEBI regulations. The presence of detailed financial statements and analysis for a period shorter than a full fiscal year (quarter and nine months) indicates this is an Interim / Quarterly Report. The document is not merely an announcement or a certification but contains substantive financial data and analysis. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2022-02-14 English
SADHANA NITROCHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2022 ,inter alia, to consider and approve Pursuant to Regulation 29 ....
Regulatory Filings Classification · 95% confidence The document is a short notice dated February 7, 2022, addressed to the stock exchange (BSE Limited) informing about a scheduled Board Meeting on February 14, 2022. The purpose of the meeting is to consider and approve the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2021. The document references compliance with SEBI regulations and insider trading rules. It does not contain any financial data or results itself, nor does it include detailed financial statements or analysis. It is an announcement of an upcoming board meeting where financial results will be considered, not the results or report itself. The document length is short (2019 characters), and it serves as a notification rather than a report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for regulatory announcements and notices that do not fit other specific categories.
2022-02-07 English
Pursuant to Regulation 30 and Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 please find enclosed copies of Newspaper advertisement issued regarding ....
Regulatory Filings Classification · 95% confidence The document contains multiple notices related to board meetings scheduled to approve un-audited standalone financial results for the quarter and nine months ended December 31, 2021. It includes references to Regulation 29 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertain to disclosure of financial results. The document also includes postal ballot notices and e-voting details for shareholder approval on equity share warrants issuance. There are no full financial statements or detailed financial analysis present, only announcements of upcoming board meetings and voting processes related to financial results and corporate actions. The document is lengthy (15,000 characters) but primarily consists of notices and announcements rather than the actual financial reports or detailed management discussions. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement and disclosure under SEBI regulations, not the actual financial report or earnings release itself.
2022-02-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.